Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Timing and Consequences on Behavior01:08

Timing and Consequences on Behavior

367
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective. 
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
367
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

841
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
841
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resective temporal lobe surgery in refractory temporal lobe epilepsy: prognostic factors of postoperative seizure outcome.

Journal of neurosurgery·2026
Same author

From mice to clinical relevance: humanizing neuroscience with human-based model systems.

Frontiers in cellular neuroscience·2026
Same author

Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

Frontiers in immunology·2026
Same author

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

medRxiv : the preprint server for health sciences·2026
Same author

Sleep magnetoencephalography enhances detection and source imaging of seizures and fast oscillations in focal cortical dysplasia.

Epilepsia·2026
Same author

Uncovering targets and molecular pathways for personalizing treatment in epilepsy.

Expert opinion on therapeutic targets·2026

Related Experiment Video

Updated: Jan 22, 2026

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.7K

[Epileptogenesis and consequences for treatment].

Ulrike B S Hedrich1, Henner Koch1, Albert Becker2

  • 1Abteilung Neurologie mit Schwerpunkt Epileptologie, Hertie-Institut für klinische Hirnforschung, Universität Tübingen, Hoppe Seyler Straße 3, 72076, Tübingen, Deutschland.

Der Nervenarzt
|June 28, 2019
PubMed
Summary

Epilepsy, a disabling neurological disorder, involves a process called epileptogenesis. Genetic defects and molecular insights are advancing personalized treatments for epilepsy syndromes.

Keywords:
Genetic epilepsiesHomeostatic regulationIon channelsNeuronal plasticityPathophysiological mechanisms

More Related Videos

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K
Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke
06:36

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke

Published on: June 5, 2019

8.8K

Related Experiment Videos

Last Updated: Jan 22, 2026

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.7K
A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K
Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke
06:36

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke

Published on: June 5, 2019

8.8K

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Epilepsy is a frequent, disabling neurological disease with a global patient burden.
  • Epileptogenesis, the process leading to seizures after an insult, is understood at the molecular level in some acquired epilepsies.
  • Genetic defects significantly contribute to understanding epileptic disease mechanisms.

Purpose of the Study:

  • To describe the correlations between genetic variants, epileptogenesis, and brain development.
  • To explore the consequences for personalized treatment possibilities in genetic epilepsy syndromes.
  • To highlight the interplay between genetic factors and the age-dependent manifestation of epilepsy.

Main Methods:

  • Review of molecular-level understanding of epileptogenesis.
  • Analysis of genetic defects contributing to epilepsy.
  • Correlation of genetic variants with epileptogenic processes and brain development.

Main Results:

  • Both molecular and genetic research have enabled personalized epilepsy treatments.
  • Genetic variants can directly cause seizures and induce epileptogenic processes.
  • Genetic factors interact with brain development, influencing age-dependent epilepsy syndrome manifestation.

Conclusions:

  • Understanding epileptogenesis and genetic defects is crucial for personalized epilepsy care.
  • Genetic variants play a complex role in epilepsy development and presentation.
  • Future treatments can be tailored based on genetic profiles and epileptogenic mechanisms.